A prospective Cohort Study of Chest Physiotherapy's Effects on Patients with Cystic Fibrosis
Keywords:
Cystic Fibrosis, Chest Physiotherapy, Forced Expiratory Volume 1Abstract
Background: Cystic fibrosis (CF) is a hereditary condition characterized by the buildup of mucus in the airways and subsequent respiratory difficulties. The present investigation, carried out between August 2022 and April 2023, examines the effects of chest physiotherapy on the well-being of a cohort of 110 individuals diagnosed with cystic fibrosis. Objective: The research specifically investigates the influence of this intervention on lung function, quality of life, and the management of symptoms. Methodology: A prospective cohort study was carried out at HMC Peshawar, strictly adhering to ethical guidelines. Lung function, quality of life (measured via CFQ-R), and respiratory symptom data were systematically collected. Results: Significant enhancements were seen promptly, as indicated by an average 7.8% augmentation in Forced Expiratory Volume in one second (FEV1) subsequent to a solitary session of chest physiotherapy. During the duration of the trial, a comprehensive examination revealed a consistent improvement in lung function, as shown by a significant increase in forced expiratory volume in one second (FEV1) from 65.3% to 74.6%. The quality of life, as measured by the CFQ-R, showed a statistically significant improvement of 12 points. There was a significant reduction in respiratory symptoms, such as coughing and difficulty breathing. Conclusion: Significant enhancements in pulmonary function were promptly noted subsequent to a solitary session of chest physiotherapy. The longitudinal analysis demonstrated a consistent and prolonged improvement in pulmonary function over the duration of the research. There was a substantial improvement in the quality of life, accompanied by a notable decrease in respiratory symptoms. The present research provides more evidence of the significant advantages of chest physiotherapy in the treatment of cystic fibrosis (CF), as shown by quantitative data that substantiates its immediate and enduring effects.References
Kriemler S, Radtke T, Christen G, Kerstan-Huber M, Hebestreit H. Short-term effect of different physical exercises and physiotherapy combinations on sputum expectoration, oxygen saturation, and lung function in young patients with cystic fibrosis. Lung. 2016;194:659-64.
Vandervoort B, De Beuckeleer D, Huenaerts E, Schulte M, Vermeulen F, Proesmans M, et al. The short term influence of chest physiotherapy on lung function parameters in children with cystic fibrosis and primary ciliary dyskinesia. Front Pediatr. 2022;10:858410.
Warnock L, Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database of Systematic Reviews. 2015(12).
Annoni S, Bellofiore A, Repossini E, Lazzeri M, Nicolini A, Tarsia P. Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review. Monaldi Arch Chest Dis. 2020;90(1).
Donadio MV, Campos NE, Vendrusculo FM, Stofella AM, da Silva Almeida AC, Ziegler B, et al. Respiratory physical therapy techniques recommended for patients with cystic fibrosis treated in specialized centers. Braz J Phys Ther. 2020;24(6):532-8.
Wallaert E, Perez T, Prevotat A, Reychler G, Wallaert B, Le Rouzic O. The immediate effects of a single autogenic drainage session on ventilatory mechanics in adult subjects with cystic fibrosis. PLoS One. 2018;13(3):e0195154.
Montero-Ruiz A, Fuentes LA, Pérez Ruiz E, GarcÃa-Agua Soler N, Rius-Diaz F, Caro Aguilera P, et al. Effects of music therapy as an adjunct to chest physiotherapy in children with cystic fibrosis: A randomized controlled trial. PloS one. 2020;15(10):e0241334.
Gruet M, Saynor ZL, Urquhart DS, Radtke T. Rethinking physical exercise training in the modern era of cystic fibrosis: A step towards optimising short-term efficacy and long-term engagement. J Cyst Fibros. 2022;21(2):e83-98.
Berthelsen D, Lund H, Ginnerup-Nielsen E, Juhl C, Henriksen M, Hróbjartsson A, et al. Comparison of treatment effect sizes associated with surrogate outcomes and patient-reported outcome measures in randomised controlled trials of physiotherapy: 2017 Protocol for a meta-epidemiological study.
Heltshe SL, Cogen J, Ramos KJ, Goss CH. Cystic fibrosis: the dawn of a new therapeutic era. Am J Respir Crit Care Med. 2017;195(8):979-84.
Paranjape SM, Mogayzel Jr PJ. Cystic fibrosis in the era of precision medicine. Paediatr Respir Rev. 2018;25:64-72.
12. Muirhead CA, Lanocha N, Markwardt S, MacDonald KD. Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations. Pediatr Pulmonol. 2021;56(5):891-900.
Somayaji R, Parkins MD, Shah A, Martiniano SL, Tunney MM, Kahle JS, et al.. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review. J Cyst Fibros. 2019;18(2):236-43.
Gifford AH, Polineni D, He J, D'Amico JL, Dorman DB, Williams MA, et al. Serum and Sputum Iron Trends Distinguish Responders and Non-Responders to Treatment of Cystic Fibrosis Pulmonary Exacerbation 2020.
Acosta N, Whelan FJ, Somayaji R, Poonja A, Surette MG, Rabin HR, et al. The evolving cystic fibrosis microbiome: a comparative cohort study spanning 16 years. Ann Am Thorac Soc. 2017;14(8):1288-97.
Agrawal A, Agarwal A, Mehta D, Sikachi RR, Du D, Wang J. Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013. Intractable Rare Dis Res. 2017;6(3):191-8.
Rasheed RA, Alsugheir FH, Alsugheir SH, Alzaaqi RA, Hijji FA, Alharbi AS, et al. Cystic fibrosis diagnosis and management in children: A simple literature review. Arch Pharma Pract. 2019;10:33-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Chest Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
